What is the equity of Harbin Pharmaceutical Group Co this year?
Harbin Pharmaceutical Group Co has equity of 4.72 B CNY this year.
Harbin Pharmaceutical Group Co Equity 2024
Harbin Pharmaceutical Group Co Equity
4.72 B CNY
Ticker
600664.SS
ISIN
CNE0000009T3
In 2024, Harbin Pharmaceutical Group Co's equity was 4.72 B CNY, a 9.07% increase from the 4.33 B CNY equity in the previous year.
Harbin Pharmaceutical Group Co Aktienanalyse
What does Harbin Pharmaceutical Group Co do?
Harbin Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Harbin Pharmaceutical Group Co's Equity
Harbin Pharmaceutical Group Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Harbin Pharmaceutical Group Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Harbin Pharmaceutical Group Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Harbin Pharmaceutical Group Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Harbin Pharmaceutical Group Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Harbin Pharmaceutical Group Co stock
What was the equity of Harbin Pharmaceutical Group Co compared to the previous year?
The equity of Harbin Pharmaceutical Group Co has increased/decreased by 9.07% increased compared to the previous year.
What impact does a high equity have on investors of Harbin Pharmaceutical Group Co?
A high equity is advantageous for investors of Harbin Pharmaceutical Group Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Harbin Pharmaceutical Group Co?
A low equity can be a risk for investors of Harbin Pharmaceutical Group Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Harbin Pharmaceutical Group Co affect the company?
An increase in equity of Harbin Pharmaceutical Group Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Harbin Pharmaceutical Group Co affect the company?
A reduction in equity of Harbin Pharmaceutical Group Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Harbin Pharmaceutical Group Co?
Some factors that can affect the equity of Harbin Pharmaceutical Group Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Harbin Pharmaceutical Group Co so important for investors?
The equity of Harbin Pharmaceutical Group Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Harbin Pharmaceutical Group Co take to change the equity?
To change equity, Harbin Pharmaceutical Group Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Harbin Pharmaceutical Group Co pay?
Over the past 12 months, Harbin Pharmaceutical Group Co paid a dividend of 0.5 CNY . This corresponds to a dividend yield of about 12.35 %. For the coming 12 months, Harbin Pharmaceutical Group Co is expected to pay a dividend of 1.02 CNY.
What is the dividend yield of Harbin Pharmaceutical Group Co?
The current dividend yield of Harbin Pharmaceutical Group Co is 12.35 %.
When does Harbin Pharmaceutical Group Co pay dividends?
Harbin Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of September, December, May, June.
How secure is the dividend of Harbin Pharmaceutical Group Co?
Harbin Pharmaceutical Group Co paid dividends every year for the past 3 years.
What is the dividend of Harbin Pharmaceutical Group Co?
For the upcoming 12 months, dividends amounting to 1.02 CNY are expected. This corresponds to a dividend yield of 25.3 %.
In which sector is Harbin Pharmaceutical Group Co located?
Harbin Pharmaceutical Group Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Harbin Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Harbin Pharmaceutical Group Co from 5/4/2018 amounting to 0.5 CNY, you needed to have the stock in your portfolio before the ex-date on 5/4/2018.
When did Harbin Pharmaceutical Group Co pay the last dividend?
The last dividend was paid out on 5/4/2018.
What was the dividend of Harbin Pharmaceutical Group Co in the year 2023?
In the year 2023, Harbin Pharmaceutical Group Co distributed 0 CNY as dividends.
In which currency does Harbin Pharmaceutical Group Co pay out the dividend?
The dividends of Harbin Pharmaceutical Group Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Harbin Pharmaceutical Group Co
Our stock analysis for Harbin Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Harbin Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Harbin Pharmaceutical Group Co Revenue
- Harbin Pharmaceutical Group Co Net Income
- Harbin Pharmaceutical Group Co P/E
- Harbin Pharmaceutical Group Co P/S
- Harbin Pharmaceutical Group Co EBIT
- Harbin Pharmaceutical Group Co Dividend
- Harbin Pharmaceutical Group Co Stocks
- Harbin Pharmaceutical Group Co Market capitalization
- Harbin Pharmaceutical Group Co Debt
- Harbin Pharmaceutical Group Co Liabilities
- Harbin Pharmaceutical Group Co Equity
- Harbin Pharmaceutical Group Co AAQS
- Harbin Pharmaceutical Group Co Employees
- Harbin Pharmaceutical Group Co ROE
- Harbin Pharmaceutical Group Co ROA
- Harbin Pharmaceutical Group Co ROCE